<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04228627</url>
  </required_header>
  <id_info>
    <org_study_id>IRB/2019/599/SIMS</org_study_id>
    <nct_id>NCT04228627</nct_id>
  </id_info>
  <brief_title>Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial</brief_title>
  <acronym>FAIR</acronym>
  <official_title>Ferritin Screening And IRon Treatment for Maternal Anemia and Fetal Growth Restriction (FGR) Prevention - a Multi Centre Randomised Controlled Trial (RCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Services Institute of Medical Sciences, Pakistan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allama Iqbal Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Services Institute of Medical Sciences, Pakistan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with
      non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a
      directly observed complete therapy, to prevent of maternal anaemia and fetal growth
      restriction. The investigators will compare this intervention with usual care in a
      multicentre randomised trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevalence of anemia (haemoglobin less than 11 gm/dl) in Asia is more than 50% and
      non-anaemic iron deficiency (ferritin less than 30 microgm/l) or NAID is likely to be more
      prevalent than this figure. It has been hypothesised that NAID in pregnancy can be linked to
      maternal fatigue and anaemia, and infant birth weight and growth restriction. The
      investigators will compare, in NAID, active intervention (therapeutic doses of parentral
      iron, as a directly observed complete therapy, to replenish iron stores) vs usual care
      (prophylactic oral iron supplementation) to prevent of maternal anaemia and fetal growth
      restriction in a multicentre randomised trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multi centre randomised trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Allocation concealment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal anaemia</measure>
    <time_frame>36 weeks' gestation</time_frame>
    <description>Haemoglobin concentration (g/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fetal growth restriction</measure>
    <time_frame>At birth</time_frame>
    <description>Birthweight for gestational age (percentile)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Iron Deficiency (Without Anemia)</condition>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous Iron to correct Iron deficiency without anaemia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prophylaxis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual antenatal care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Parentral Iron</intervention_name>
    <description>Correction of Iron stores without anaemia</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-anaemic iron deficiency

        Exclusion Criteria:

          -  Anaemia or normal iron stores
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>TAYYIBA Wasim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Services Institute of Medical Sciences, Pakistan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TAYYIBA Wasim</last_name>
    <phone>03008400197</phone>
    <email>tayyibawasim@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>TAYYIBA Wasim</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <zip>54590</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TAYYIBA Wasim</last_name>
      <phone>03008400197</phone>
      <email>tayyibawasim@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allama Iqbal Medical College</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Pratt JJ, Khan KS. Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol. 2016 Jun;96(6):618-28. doi: 10.1111/ejh.12645. Epub 2015 Sep 17. Review.</citation>
    <PMID>26256281</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2020</study_first_posted>
  <last_update_submitted>January 11, 2020</last_update_submitted>
  <last_update_submitted_qc>January 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Services Institute of Medical Sciences, Pakistan</investigator_affiliation>
    <investigator_full_name>Tayyiba Wasim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>anemia, ferritin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>On completion of study we will happily discuss data sharing with any legitimate party with an IPD meta-analysis protocol.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Following publication of study</ipd_time_frame>
    <ipd_access_criteria>An acceptable IPD meta-analysis protocol with a suitable data sharing agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

